source
- BRUIN CLL-321 Trial Impact and Treatment SelectionExperts outline relapse workup in CLL, using PET-CT and biopsy for suspected Richter’s, plus resistance and TP53 testing to guide next therapy.onclive · 2mo ago↗ source
- Biomarker-Driven Treatment Decisions and Managing Progression After Frontline ImmunotherapyUpfront biomarker testing reshapes endometrial cancer care, guiding targeted and immune therapy—and exposing gaps in second-line options.onclive · 2mo ago↗ source
- Extreme heat is worsening faster for Black AmericansBill Cassidy's can't-win conundrum, what RFK Jr. gets right and wrong about antidepressants, and more health newsSTAT · 2mo ago↗ source